Patents Represented by Attorney Glen Gesicki

Find this attorney in the Justia Lawyer Directory

  • Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
    Patent number: 8063091
    Abstract: Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: July 22, 2009
    Date of Patent: November 22, 2011
    Assignee: Abbott Laboratories
    Inventors: Yujia Dai, Steven K. Davidsen, Anna M. Ericsson, Kresna Hartandi, Zhiqin Ji, Michael R. Michaelides
  • Crystalline chemotherapeutic
    Patent number: 7994208
    Abstract: N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N?-(2-fluoro-5-methylphenyl)urea·¼ Ethanolate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it is disclosed.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: August 9, 2011
    Assignee: Abbott Laboratories
    Inventor: Thomas B. Borchardt
  • Crystalline chemotherapeutic
    Patent number: 7947843
    Abstract: N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N?-(2-fluoro-5-methylphenyl)urea Hydrate Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: May 24, 2011
    Assignee: Abbott Laboratories
    Inventors: Thomas B. Borchardt, Michael J. Rozema, Shailendra V. Bordawekar, Alexander F. Chu-Kung
  • Crystalline chemotherapeutic
    Patent number: 7943782
    Abstract: N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N?-(2-fluoro-5-methylphenyl)urea Tolueneate Crystalline Form 1, ways to make it and ways to use it are disclosed.
    Type: Grant
    Filed: October 15, 2008
    Date of Patent: May 17, 2011
    Assignee: Abbott Laboratories
    Inventor: Rodger F. Henry